866-997-4948(US-Canada Toll Free)

Alzheimers Disease - Pipeline Review, H1 2014

Published By :

Global Markets Direct

Published Date : Feb 2014

Category :

Diseases & Conditions

No. of Pages : 1242 Pages

Global Markets Direct’s, ‘Alzheimer\'s Disease - Pipeline Review, H1 2014’, provides an overview of the Alzheimer\'s Disease’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Alzheimer\'s Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Alzheimer\'s Disease and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Alzheimer\'s Disease
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Alzheimer\'s Disease and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Alzheimer\'s Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Alzheimer\'s Disease pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Alzheimer\'s Disease
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Alzheimer\'s Disease pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Content

Introduction
Alzheimer\'s Disease Overview
Therapeutics Development
Alzheimer\'s Disease - Therapeutics under Development by Companies
Alzheimer\'s Disease - Therapeutics under Investigation by Universities/Institutes
Alzheimer\'s Disease - Pipeline Products Glance
Alzheimer\'s Disease - Products under Development by Companies
Alzheimer\'s Disease - Products under Investigation by Universities/Institutes
Alzheimer\'s Disease - Companies Involved in Therapeutics Development
Alzheimer\'s Disease - Therapeutics Assessment
Drug Profiles
Alzheimer\'s Disease - Recent Pipeline Updates
Alzheimer\'s Disease - Dormant Projects
Alzheimer\'s Disease - Discontinued Products
Alzheimer\'s Disease - Product Development Milestones

Appendix

List of Table


Number of Products under Development for Alzheimer\'s Disease, H1 2014
Number of Products under Development for Alzheimer\'s Disease - Comparative Analysis, H1 2014
Number of Products under Development by Companies, H1 2014
Number of Products under Development by Companies, H1 2014 (Contd..1)
Number of Products under Development by Companies, H1 2014 (Contd..2)
Number of Products under Development by Companies, H1 2014 (Contd..3)
Number of Products under Development by Companies, H1 2014 (Contd..4)
Number of Products under Development by Companies, H1 2014 (Contd..5)
Number of Products under Development by Companies, H1 2014 (Contd..6)
Number of Products under Development by Companies, H1 2014 (Contd..7)
Number of Products under Development by Companies, H1 2014 (Contd..8)
Number of Products under Development by Companies, H1 2014 (Contd..9)
Number of Products under Development by Companies, H1 2014 (Contd..10)
Number of Products under Development by Companies, H1 2014 (Contd..11)
Number of Products under Development by Companies, H1 2014 (Contd..12)
Number of Products under Development by Companies, H1 2014 (Contd..13)
Number of Products under Development by Companies, H1 2014 (Contd..14)
Number of Products under Development by Companies, H1 2014 (Contd..15)
Number of Products under Development by Companies, H1 2014 (Contd..16)
Number of Products under Development by Companies, H1 2014 (Contd..17)
Number of Products under Investigation by Universities/Institutes, H1 2014
Number of Products under Investigation by Universities/Institutes, H1 2014 (Contd..1)
Number of Products under Investigation by Universities/Institutes, H1 2014 (Contd..2)
Number of Products under Investigation by Universities/Institutes, H1 2014 (Contd..3)
Number of Products under Investigation by Universities/Institutes, H1 2014 (Contd..4)
Number of Products under Investigation by Universities/Institutes, H1 2014 (Contd..5)
Number of Products under Investigation by Universities/Institutes, H1 2014 (Contd..6)
Number of Products under Investigation by Universities/Institutes, H1 2014 (Contd..7)
Comparative Analysis by Late Stage Development, H1 2014
Comparative Analysis by Clinical Stage Development, H1 2014
Comparative Analysis by Early Stage Development, H1 2014
Comparative Analysis by Unknown Stage Development, H1 2014
Products under Development by Companies, H1 2014
Products under Development by Companies, H1 2014 (Contd..1)
Products under Development by Companies, H1 2014 (Contd..2)
Products under Development by Companies, H1 2014 (Contd..3)
Products under Development by Companies, H1 2014 (Contd..4)
Products under Development by Companies, H1 2014 (Contd..5)
Products under Development by Companies, H1 2014 (Contd..6)
Products under Development by Companies, H1 2014 (Contd..7)
Products under Development by Companies, H1 2014 (Contd..8)
Products under Development by Companies, H1 2014 (Contd..9)
Products under Development by Companies, H1 2014 (Contd..10)
Products under Development by Companies, H1 2014 (Contd..11)
Products under Development by Companies, H1 2014 (Contd..12)
Products under Development by Companies, H1 2014 (Contd..13)
Products under Development by Companies, H1 2014 (Contd..14)
Products under Development by Companies, H1 2014 (Contd..15)
Products under Development by Companies, H1 2014 (Contd..16)
Products under Development by Companies, H1 2014 (Contd..17)
Products under Development by Companies, H1 2014 (Contd..18)
Products under Development by Companies, H1 2014 (Contd..19)
Products under Development by Companies, H1 2014 (Contd..20)
Products under Development by Companies, H1 2014 (Contd..21)
Products under Development by Companies, H1 2014 (Contd..22)
Products under Development by Companies, H1 2014 (Contd..23)
Products under Development by Companies, H1 2014 (Contd..24)
Products under Development by Companies, H1 2014 (Contd..25)
Products under Development by Companies, H1 2014 (Contd..26)
Products under Development by Companies, H1 2014 (Contd..27)
Products under Development by Companies, H1 2014 (Contd..28)
Products under Investigation by Universities/Institutes, H1 2014
Products under Investigation by Universities/Institutes, H1 2014 (Contd..1)
Products under Investigation by Universities/Institutes, H1 2014 (Contd..2)
Products under Investigation by Universities/Institutes, H1 2014 (Contd..3)
Products under Investigation by Universities/Institutes, H1 2014 (Contd..4)
Products under Investigation by Universities/Institutes, H1 2014 (Contd..5)
Products under Investigation by Universities/Institutes, H1 2014 (Contd..6)
Products under Investigation by Universities/Institutes, H1 2014 (Contd..7)
Products under Investigation by Universities/Institutes, H1 2014 (Contd..8)
Products under Investigation by Universities/Institutes, H1 2014 (Contd..9)
Alzheimer\'s Disease - Pipeline by Bristol-Myers Squibb Company, H1 2014
Alzheimer\'s Disease - Pipeline by Johnson & Johnson, H1 2014
Alzheimer\'s Disease - Pipeline by Boehringer Ingelheim GmbH, H1 2014
Alzheimer\'s Disease - Pipeline by F. Hoffmann-La Roche Ltd., H1 2014
Alzheimer\'s Disease - Pipeline by Biogen Idec Inc., H1 2014
Alzheimer\'s Disease - Pipeline by OXIS International, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Shionogi & Co., Ltd., H1 2014
Alzheimer\'s Disease - Pipeline by NsGene A/S, H1 2014
Alzheimer\'s Disease - Pipeline by Amgen Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Sanofi, H1 2014
Alzheimer\'s Disease - Pipeline by AstraZeneca PLC, H1 2014
Alzheimer\'s Disease - Pipeline by Eli Lilly and Company, H1 2014
Alzheimer\'s Disease - Pipeline by Perrigo Company, H1 2014
Alzheimer\'s Disease - Pipeline by GlaxoSmithKline plc, H1 2014
Alzheimer\'s Disease - Pipeline by Genentech, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by MedImmune, LLC, H1 2014
Alzheimer\'s Disease - Pipeline by Merck & Co., Inc., H1 2014
Alzheimer\'s Disease - Pipeline by United Biomedical, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Dainippon Sumitomo Pharma Co., Ltd., H1 2014
Alzheimer\'s Disease - Pipeline by Taisho Pharmaceutical Co., Ltd., H1 2014
Alzheimer\'s Disease - Pipeline by Euroscreen S.A., H1 2014
Alzheimer\'s Disease - Pipeline by Applied NeuroSolutions, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Sangamo BioSciences, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by NeuroDerm Ltd., H1 2014
Alzheimer\'s Disease - Pipeline by Plexxikon Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Biotherapix SLU, H1 2014
Alzheimer\'s Disease - Pipeline by Avineuro Pharmaceuticals, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Panacea Pharmaceuticals, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Nanotherapeutics, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Novartis AG, H1 2014
Alzheimer\'s Disease - Pipeline by Aphios Corporation, H1 2014
Alzheimer\'s Disease - Pipeline by Alzhyme Ltd., H1 2014
Alzheimer\'s Disease - Pipeline by EnVivo Pharmaceuticals, H1 2014
Alzheimer\'s Disease - Pipeline by Astellas Pharma Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Daewoong Pharmaceutical Co., Ltd., H1 2014
Alzheimer\'s Disease - Pipeline by Eisai Co., Ltd., H1 2014
Alzheimer\'s Disease - Pipeline by H. Lundbeck A/S, H1 2014
Alzheimer\'s Disease - Pipeline by Jeil Pharmaceutical Co., Ltd., H1 2014
Alzheimer\'s Disease - Pipeline by Les Laboratoires Servier SAS, H1 2014
Alzheimer\'s Disease - Pipeline by Mitsubishi Tanabe Pharma Corporation, H1 2014
Alzheimer\'s Disease - Pipeline by Octapharma AG, H1 2014
Alzheimer\'s Disease - Pipeline by Orion Oyj, H1 2014
Alzheimer\'s Disease - Pipeline by Pain Therapeutics, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Pfizer Inc., H1 2014
Alzheimer\'s Disease - Pipeline by SK Chemicals Co., Ltd., H1 2014
Alzheimer\'s Disease - Pipeline by Teva Pharmaceutical Industries Limited, H1 2014
Alzheimer\'s Disease - Pipeline by Toyama Chemical Co., Ltd., H1 2014
Alzheimer\'s Disease - Pipeline by Vivus, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Hadasit Medical Research Services & Development Ltd, H1 2014
Alzheimer\'s Disease - Pipeline by Addex Therapeutics, H1 2014
Alzheimer\'s Disease - Pipeline by Evotec AG, H1 2014
Alzheimer\'s Disease - Pipeline by Anavex Life Sciences Corp., H1 2014
Alzheimer\'s Disease - Pipeline by Neuralstem, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Genfit SA, H1 2014
Alzheimer\'s Disease - Pipeline by Avanir Pharmaceuticals, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Lupin Limited, H1 2014
Alzheimer\'s Disease - Pipeline by Bionomics Limited, H1 2014
Alzheimer\'s Disease - Pipeline by ReGenX Biosciences, LLC, H1 2014
Alzheimer\'s Disease - Pipeline by Nymox Pharmaceutical Corporation, H1 2014
Alzheimer\'s Disease - Pipeline by Paladin Labs Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Critical Outcome Technologies Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Acadia Pharmaceuticals Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Oligomerix, inc., H1 2014
Alzheimer\'s Disease - Pipeline by ProteoTech, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Prana Biotechnology Limited, H1 2014
Alzheimer\'s Disease - Pipeline by Xenetic Biosciences plc, H1 2014
Alzheimer\'s Disease - Pipeline by Biotie Therapies Corp., H1 2014
Alzheimer\'s Disease - Pipeline by Neurim Pharmaceuticals Ltd, H1 2014
Alzheimer\'s Disease - Pipeline by Theravance, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Resverlogix Corp., H1 2014
Alzheimer\'s Disease - Pipeline by Suven Life Sciences Ltd., H1 2014
Alzheimer\'s Disease - Pipeline by Summit Corporation plc, H1 2014
Alzheimer\'s Disease - Pipeline by CrystalGenomics, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Mithridion, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Teikoku Pharma USA, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by tesa Labtec GmbH, H1 2014
Alzheimer\'s Disease - Pipeline by Eisai Ltd., H1 2014
Alzheimer\'s Disease - Pipeline by Oryzon Genomics S.A., H1 2014
Alzheimer\'s Disease - Pipeline by Spectrum Pharmaceuticals, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by TauRx Therapeutics Ltd, H1 2014
Alzheimer\'s Disease - Pipeline by CoMentis, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by AC Immune SA, H1 2014
Alzheimer\'s Disease - Pipeline by Humanetics Corporation, H1 2014
Alzheimer\'s Disease - Pipeline by Accera, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Sonexa Therapeutics, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by D-Pharm Ltd., H1 2014
Alzheimer\'s Disease - Pipeline by StemCells, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Proteome Sciences Plc, H1 2014
Alzheimer\'s Disease - Pipeline by Upsher-Smith Laboratories, Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Probiodrug AG, H1 2014
Alzheimer\'s Disease - Pipeline by Snowdon Inc., H1 2014
Alzheimer\'s Disease - Pipeline by Domain Therapeutics SA, H1 2014

List of Chart


Number of Products under Development for Alzheimer\'s Disease, H1 2014
Number of Products under Development for Alzheimer\'s Disease - Comparative Analysis, H1 2014
Number of Products under Development by Companies, H1 2014
Number of Products under Investigation by Universities/Institutes, H1 2014
Comparative Analysis by Late Stage Development, H1 2014
Comparative Analysis by Clinical Stage Development, H1 2014
Comparative Analysis by Early Stage Products, H1 2014
Assessment by Monotherapy Products, H1 2014
Assessment by Combination Products, H1 2014
Number of Products by Top 10 Target, H1 2014
Number of Products by Stage and Top 10 Target, H1 2014
Number of Products by Top 10 Mechanism of Action, H1 2014
Number of Products by Stage and Top 10 Mechanism of Action, H1 2014
Number of Products by Top 10 Route of Administration, H1 2014
Number of Products by Stage and Top 10 Route of Administration, H1 2014
Number of Products by Top 10 Molecule Type, H1 2014
Number of Products by Stage and Top 10 Molecule Type, H1 2014

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *